Competition from Medtronic plc hurt Boston Scientific Corp.'s cardiac rhythm management (CRM) business in the fourth quarter, analysts noted after Boston Scientific reported its earnings for the quarter.
Although definitions of personalized medicine vary greatly from one person and organization to the next, the term gets thrown around a lot in the context of oncology — for good reason. There simply is no one-size-fits-all approach to fighting cancer.
RSS